A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer

Anticancer Research

Volumn 30, Issue 11, 2010, Pages 4711-4715

  Pouessel, Damien ^a,e   Huguet, Helena ^a   Iborra, François ^b   Rebillard, Xavier ^c   Ayuso, Didier ^d   Becht, Catherine ^a   Culine, Stéphane ^a,e  

^a CENTRE VAL D AURELLE   (France)

^b Clinique du Millenaire   (France)

^c Clinique Beausoleil   (France)

^d CENTRE HOSPITALIER   (France)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

Advanced bladder carcinoma; Gemcitabine; Oxaliplatin; Vinorelbine

Indexed keywords

GEMCITABINE; NAVELBINE; OXALIPLATIN;

ADRENAL METASTASIS; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; ASTHENIA; BLADDER CANCER; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; HEMATOMA; HUMAN; INFECTION; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PELVIS METASTASIS; PERIPHERAL NEUROPATHY; PERITONEUM METASTASIS; PILOT STUDY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; DEOXYCYTIDINE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PILOT PROJECTS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 78650238562     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sternberg CN, de Mulder P, Schornagel JH, Theodore C, Fossa SD, van Oosterom AT, Witjes JA, Spina M, van Groeningen CJ, Duclos B, Roberts JT, de Balincourt C and Colette L: Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours. Eur J Cancer 42: 50-54, 2006.
2. von der Maase H, Hansen SW, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A and Arning M: Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23: 4602-4608, 2005.
3. Winquist E, Vokes E, Moore MJ, Schumm LP, Hoving K and Stadler WM: A phase II study of oxaliplatin in urothelial cancer. Urol Oncol 23: 150-154, 2005.
4. Türkölmez K, Bedük Y, Baltaci S, Gögüs C and Gögüs O: Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy. Eur Urol 44: 682-686, 2003.
5. Culine S, Rebillard X, Iborra F, Mottet N, Faix A, Ayuso D and Pinguet F: Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study. Anticancer Res 23: 1903-1906, 2003.
6. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, Gunderson L, McCormick B, Morrisintegral M, Rich T, Shipley W and Curran W: Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47: 13-47, 2000.
7. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC and Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92: 205-216, 2000. (Pubitemid 30099779)
8. Bajorin DF, Dodd PM, Mazumdar M, Fazzari M, McCaffrey JA, Scher HI, Herr H, Higgins G and Boyle MG: Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 17: 3173-3181, 1999.
9. Trédaniel J, Becht C, Bekradda M, De Cremoux H, Alexandre J, Chomy F, Szyldergemajn S, Yataghene Y, Culine S et al: An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients. Lung Cancer 63: 259-263, 2009.
10. Théodore C, Bidault F, Bouvet-Forteau N, Abdelatif M, Fizazi K, di Palma M, Wibault P, de Crevoisier R and Laplanche A: A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma of the urothelial tract. Ann Oncol 17: 990-994, 2006.
11. Carles J, Esteban E, Climent M, Font A, Gonzalez-Larriba JL, Berrocal A, Garcia-Ribas I, Marfa X, Fabregat X, Albanell J and Bellmunt J: Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer. Ann Oncol 18: 1359-1362, 2007.
12. Bellmunt J, Théodore C, Demkov T, Komyakov B, Sengelov L, Daugaard G, Caty A, Carles J, Jagiello-Graszfeld A, Karyakin O, Delgaldo FM, Hurteloup P, Winquist E, Morsli N, Salhi Y, Culine S and von der Maase H: Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. J Clin Oncol 27: 4454-4461, 2009.